Table 2 Results of base-case analysis
Treatment | Cumulative cost ($) | Cumulative life years (Years) | Cumulative effectiveness (QALY) | Incremental cost ($) | Incremental effectiveness (QALY) | ICER ($/QALY) |
|---|---|---|---|---|---|---|
NALIRIFOX | 216,397.03 | 1.51 | 0.94 | 59,838.80 | 0.29 | 206,340.69 |
Nab-paclitaxel and Gemcitabine | 156,558.23 | 1.07 | 0.65 |